AKT1 and non-small cell lung carcinoma: Via GSEA, a luciferase reporter assay, western blotting, immunostaining, and so on (Fig. 6), this study systemically proved that WTIP potentiates cell proliferation and the tumorigenesis of NSCLC by attenuating AKT activity and enhancing FOXO1 expression and transcriptional activity.